3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Interventions
Oxaliplatin
86
Capecitabine
66
Bevacizumab
65
Fluorouracil
48
tislelizumab
41
Gemcitabine
39
Drug Therapy
39
Leucovorin
38
sintilimab
35
Irinotecan
34
Cisplatin
28
lenvatinib
26
HMPL-013
25
S 1 (combination)
24
camrelizumab
22
Immune Checkpoint Inhibitors
21
irinotecan sucrosofate
20
apatinib
20
Surgical Procedures, Operative
20
Radiotherapy
20
Injections
20
130-nm albumin-bound paclitaxel
20
toripalimab
18
Paclitaxel
18
Folfox protocol
17
pembrolizumab
16
Immunotherapy
15
Cetuximab
15
Specimen Handling
14
regorafenib
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Histamine
×
Gastrointestinal
×
Clear all
NCT05810792
2023-11-22
PANCEP-1
Sahlgrenska University Hospital
Phase 2
Not yet recruiting
50 enrolled